AstraZeneca is likely to run an additional global trial to assess the efficacy of its COVID-19 vaccine candidate, the company’s CEO tells Bloomberg.
Posted in
#canadahealth #canadahealthy #canadalistings #canadastory #canadianhealth Health Search Canada Online Listing

